The stent is intended to treat ureteral obstructions that prevent urine in the kidneys from draining into the bladder.
The device can convert from a catheter to a stent — first draining urine from the patient before acting as a stent to fix the blockage — eliminating clinician’s need to perform two separate procedures.
“The ConvertX System saves the patient the risk and discomfort of an additional second interventional procedure and may reduce healthcare costs, free up the hospital’s angio suite for other procedures and save the IR procedural time that can be devoted to care of other patients,” said Bob Smouse, MD, founder and CEO of Mountain View, Calif.-based BrightWater Medical.
More articles on supply chain:
Court orders contracted pilots for Amazon, DHL to return to work after strike
DEA bans furanyl fentanyl
4 threats to the US blood supply
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
